The significance of gastrectomy in advanced gastric cancer patients with non-curative factors

Anticancer Research

Volumn 28, Issue 4 C, 2008, Pages 2379-2384

  Miyagaki, H ^a   Fujitani, Kazumasa ^a,b   Tsujinaka, T ^a   Hirao, M ^a   Yasui, M ^a   Kashiwazaki, M ^a   Ikenaga, M ^a   Miyazaki, M ^a   Mishima, H ^a   Nakamori, S ^a  

^a OSAKA NATIONAL HOSPITAL   (Japan)

^b NONE   (Japan)

Author keywords

Advanced gastric cancer; Gastrectomy; Non curative factor; Prognostic factor

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CISPLATIN; DOXIFLURIDINE; IRINOTECAN; PACLITAXEL; UFT;

ADULT; ADVANCED CANCER; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ANOREXIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CONTROLLED STUDY; DIARRHEA; FEMALE; GASTRECTOMY; HUMAN; LENGTH OF STAY; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NAUSEA; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SIDE EFFECT; STOMACH CANCER; STOMATITIS; SURVIVAL RATE; SURVIVAL TIME; THERAPY EFFECT; THROMBOCYTOPENIA; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; FEMALE; GASTRECTOMY; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; QUALITY OF LIFE; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 48849109132     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Kikuchi S, Arai Y, Morise M, Kobayashi N, Tsukamoto H, Shimao H, Sakakibara Y, Hiki Y and Kakita A: Gastric cancer with metastasis to the distant peritoneum: a 20-year surgical experience. Hepatogastroenterology 22: 1183-1188, 1998.
2. Ouchi K, Sugawara T, Ono H, Fujiya T, Kamiyama Y, Kakugawa Y, Mikuni J and Yamanami Y: Therapeutic significance of palliative operations for gastric cancer for survival and quality of life. J Surg Oncol 69: 41-44, 1998.
3. Japanese Classification of Gastric Carcinoma - 2nd English Edition. Gastric Cancer 1: 10-24, 1998.
4. Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, Furukawa H, Nakajima T, Ohashi Y, Imamura H, Higashino M, Yamamura Y, Kurita A and Arai K: Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 357: 1810-1820, 2007.
5. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Glabbeke van M, Oosterom van AT, Christian MC and Gwyther SG: New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92: 205-216, 2000.
6. Common Terminology Criteria for Adverse Events v3.0 (CTCAE): Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI) 2003.
7. Lehnert T, Rudek B, Kienle P, Buhl K and Herfarth C: Impact of diagnostic laparoscopy on the management of gastric cancer: Prospective study of 120 consecutive patients with primary gastric adenocarcinoma. Br J Surg 89: 471-475, 2002.
8. Bonenkamp JJ, Songun I, Hermans J, Sasako M, Welvaart K, Plukker JTM, Elk van P, Obertop H, Gouma DJ, Taar CW, Lanschot van J, Meyer S, Graaf de PW, Meyenfeldt von MF, Tilanus H and van de Velde CJH: Randomized comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 345: 745-748, 1995.
9. Hanazaki K, Sodeyama H, Mochizuki Y, Igarashi J, Yokoyama S, Sode Y, Wakabayashi M, Kawamura N and Miyazaki T: Palliative gastrectomy for advanced gastric cancer. Hepatogastroenterology 48: 285-289, 2001.
10. Maekawa S, Saku M, Maehara Y, Sadanaga N, Ikejiri K, Anai H, Kuwano H and Sugimachi K: Surgical treatment for advanced gastric cancer. Hepatogastroenterology 43: 178-186, 1996.
11. Miner TJ, Jaques DP, Karpeh MS and Brennan MF: Defining palliative surgery in patients receiving non-curative resections for gastric cancer. J Am Coll Surg 198: 1013-1021, 2004.
12. Hartgrink HH, Putter H, Kranenbarg EK, Bonenkamp JJ and van de Velde CJH. Dutch Gastric Cancer Group: Value of palliative resection in gastric cancer. Br J Surg 89: 1438-1443, 2002.
13. Bonenkamp JJ, Sasako M, Hermans J and van de Velde CJH: Tumor load and surgical palliation in gastric cancer. Hepatogastroenterology 48: 1219-1221, 2001.
14. Haugstvedt T, Viste A, Eide GE, Real C and Soreide O: The survival benefit of resection in patients with advanced stomach cancer: the Norwegian multicenter experience. World J Surg 13: 617-621, 1989.
15. Bozzetti F, Bonfanti G, Audisio RA, Doci R, Dossena G, Gennari L and Andreola S: Prognosis of patients after palliative surgical procedures for carcinoma of the stomach. Surg Gynecol Obstet 164: 151-154,1987.
16. Koga S, Kawaguchi H, Kishimoto H, Tanaka K, Miyano Y, Kimura O, Takeda R and Nishidoi H: Therapeutic significance of non-curative gastrectomy for gastric cancer with liver metastasis. Am J Surg 140: 356-359, 1980.
17. Kahlke V, Bestmann B, Schmid A, Doniec JM, Kuchler T and Kremer B: Palliation of metastatic gastric cancer: impact of preoperative symptoms and the type of operation on survival and quality of life. World J Surg 28: 369-375, 2004.
18. Kunisaki C, Shimada H, Akiyama H, Nomura M, Matsuda G and Ono H: Survival benefit of palliative gastrectomy in advanced incurable gastric cancer. Anticancer Res 23: 1853-1858, 2003.
19. Yoshikawa T, Kanari M, Tsuburaya A, Kobayashi O, Sairenji M, Motohashi H and Noguchi Y: Should gastric cancer with peritonel metastasis be treated surgically? Hepatogastroenterology 50: 1712-1715, 2003.
20. Hoya Y, Yamazaki Y and Ohta K: A study of the appropriate operation for surgical curability C in patients with advanced gastric cancer. Tokyo Jikeikai Med J 116: 183-188, 2001 (In Japanese).